DUBLIN, July 4, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vb89tc/global_ovarian) has announced the addition of the "Global Ovarian Cancer Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages.
It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.
The analysts forecast the Global Ovarian Cancer market will grow at a CAGR of 13.85 percent over the period 2013-2018.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Rate of Incidence and Prevalence
08. Market Segmentation by Type of Therapy
09. Pipeline Portfolio
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
Companies Mentioned:
- Aetera Zenteris Inc.
- Amgen Inc.
- Aprea AB
- Astra Zeneca plc
- Bionumerik Pharmaceuticals Inc.
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Company
- Eli Lilly and Company
- F. Hoffman-La Roche Ltd
- Genentech Inc.
- GlaxoSmithKline plc
- Janssen Pharmaceuticals Inc.
- MEI Pharmaceuticals Inc.
- Nektar Therapeutics
- NeoPharm Inc.
- Novogen Inc.
- Oasmia Pharmaceuticals AB
- Synta Pharmaceuticals Corp.
For more information visit http://www.researchandmarkets.com/research/vb89tc/global_ovarian
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article